
Russell Publishing Ltd
Court Lodge
Hogtrough Hill
Brasted
Kent TN16 1NU. UK
Registered in England
No. 2709148
Registered office as above.
VAT No. GB 577 897847
|
| Latest News | Editor's Corner | Pfizer triumphs at environmental awards The best in UK environmental excellence was celebrated on 1 July at the 2009 Business Commitment to the Environment (BCE) Environmental Leadership Awards in London...best in UK environmental excellence was celebrated on 1 July at the 2009 Business Commitment to the Environment (BCE) Environmental Leadership Awards in London... read more _____________________________
BASi opens new facility in Europe to better serve pharmaceutical and biotech companies BASi, a leading provider of contract laboratory services and manufacturer of scientific instruments in the US, has opened a new European laboratory and office in Warwickshire, UK... read more _____________________________ IChemE President awarded CBE IChemE President, Ian Shott has been awarded a CBE (Commander of the British Empire) in recognition of his services to the chemical engineering industry... read more _____________________________ ICON Announces Collaboration to Develop New Translational Medicine Unit at Purpose-built Hospital Facility in Manchester Dublin, Ireland, June 16th, 2009 ICON plc, (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has signed a collaborative agreement with the Central Manchester University Hospitals Foundation (CMFT) to develop a purpose built translational medicine facility... read more _____________________________ Biopartners Appoints Dr Conrad Savoy as CEO Biopartners GmbH has announced the appointment of Dr Conrad Savoy as its new CEO and President of the Board from the 1st of May 2009... read more _____________________________ Cancer Congress Update set to launch in UK The programme for the UK's first Cancer Congress Update (CCU) has been announced... read more _____________________________ Heptares moves to Welwyn BioPark and plans further expansion Heptares Therapeutics Ltd, the drug discovery company focused on G-protein-coupled receptor (GPCR) targets, announces that it is relocating to the BioPark in Welwyn Garden City, between London and Cambridge, from its laboratories in Mill Hill, North London, where it has been based since founding in 2007... read more _____________________________
>>Read more news stories
| 
Welcome back to the European Pharmaceutical Review site!
As we all know it has been a some what difficult few weeks for many politicians in the UK and now a large percentage of voters have retaliated to the outlandish expenses claims (Duck Island anybody?) by not voting for the ‘big three' parties.
Europe is now looking at a different parliament where right-wing parties are more prominent and Labour is not such a strong force. Whether this is a step forward or back for the EU is a huge talking point but how will this new style of European Parliament affect European science?
This week I came across a Science Blog on the Guardian website which highlighted just how little time the ‘big three' parties dedicate to scientific issues; commitment to research gets a small mention and their positions on areas such as stem cell research and genetic modification are unclear. Then there are other key parties, the Green Party for example, who are proposing an EU-wide ban on embryonic stem cell research. If our parties aren't sure where they stand on important scientific issues then where should the science community turn?
I'd love to hear your opinions on the current political status of the UK and the EU and how you think it will affect you as scientists in the future.
Interested in contributing editorial?
If you have an interesting project or any opinions that you would like to share with our readers, please contact me, I'd love to hear from you.
Email me | Our top 5 articles from the latest issue
| Dates for your diary | Biomarkers in CNS drug discovery and development - focus on molecular blood markers Irina Antonijevic, Director of Translational Research, Lundbeck Research USA In established economies, mental disorders account for a larger burden of disease than all cancers combined... Read article in full _________________________________ | »11th International Congress on Amino Acids, Peptides & Proteins Date: 3 - 7 August 2009 Location: Vienna, Austria View Website ________
»Pharma CI Date: 15 - 16 September 2009 Location: New Jersey View Website ________
»World Drug Safety Congress Date: 15 - 18 September 2009 Location: London, UK View Website ________ »The World Stem Cell Summit 2009 Date: 21 - 23 September 2009 Location: Baltimore, USA View Website ________ »European Biomarkers Summit Date: 5 - 6 November 2009 Location: Barcelona, Spain View Website ________ »Proteomics Europe Date: 5-6 November 2009 Location: Barcelona, Spain View Website
________ »Mass Spec Europe Date: 5-6 November 2009 Location: Barcelona, Spain View Website ________
»Stem Cells: A Pathway Through the Maze Date: 10 - 11 December 2009 Location: Oxford, UK View Website | Quantitative Proteomics for Systems Biology Dr Claire Eyers, Deputy Director, Michael Barber Centre for Mass Spectrometry, University of Manchester The pharmaceutical industry continues to experience a high attrition rate during the latter stages of small molecule therapeutic development, most disappointingly during the late, and highly expensive stages of Phase II and Phase III trial1. Read article in full _________________________________ | Cellular reprogramming and its implications for therapeutic applications Dr Jens Schwamborn, Group Leader Münster University and Lai Wen, Visiting Scholar, Münster University
Nearly fifty years ago, it was hypothesised that terminally differentiated cells such as fibroblasts could be forced to take on a pluripotent state, similar to the embryonic stem cells (ES cells)... Read article in full _______________________________ | High Content Analysis Roundtable Anthony Davies, Director of High Content Research Facility, Department of Clinical Medicine, Trinity College Dublin, Sarah Payne, Product Manager, TTP LabTech Limited, Khuong Truong, European Product Manager, BD Biosciences, Jeremy Simpson, Professor of Cell Biology, University College Dublin (UCD), Oscar 'Joe' Trask, Head of Cellular Imaging Technologies, Duke University, Peter Simpson, Associate Director of Cancer Bioscience, AstraZeneca
1. How significantly do you feel the Drug Discovery Process has benefited from the application of High Content Analysis techniques?...
Read article in full _______________________________ | Applying PAT in Chemical Process Development Mario Hellings, Scientist, Tom Van den Kerkhof, Senior Scientist and Koen De Smet, Senior Technology Engineer, Johnson & Johnson As the time-to-market of pharmaceutical products has elongated, while its prices are under big pressure, cost saving is currently essential in the pharmaceutical industry... Read article in full _____________________________ | | If you would like to view the lastest issue in full, please click here |
|
EPRD issue 2/09 out now!

|